Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$28.28 USD
-0.10 (-0.35%)
Updated May 17, 2024 04:00 PM ET
After-Market: $28.29 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Dentsply International (XRAY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$34.42 | $38.00 | $30.00 | 21.28% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Dentsply International comes to $34.42. The forecasts range from a low of $30.00 to a high of $38.00. The average price target represents an increase of 21.28% from the last closing price of $28.38.
Analyst Price Targets (13)
Broker Rating
Dentsply International currently has an average brokerage recommendation (ABR) of 1.96 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.96 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, six are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 42.86% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.96 | 1.96 | 1.96 | 1.96 | 2.13 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/3/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Hold | Hold |
5/3/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
5/2/2024 | William Blair | Brandon Vazquez | Strong Buy | Strong Buy |
5/2/2024 | Piper Sandler | Jason Bednar | Hold | Hold |
3/1/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
2/29/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.96 |
ABR (Last week) | 1.96 |
# of Recs in ABR | 14 |
Average Target Price | $34.42 |
LT Growth Rate | 11.20% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 146 of 252 |
Current Quarter EPS Est: | 0.51 |